Global Hemostatic Agents Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Hemostatic Agents Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2034694
  • Published Date :
    May 1, 2022
  • Number of Pages :
    300.0

Product Description

Haemostatics are applications designed to stem blood-flow through the accelerated promotion of clotting.  Topical hemostatic agents can be divided into three basic categories: fibrin sealants; autologous platelet gel; and commercial derivatives of collagen, gelatin, and cellulose that provide a matrix for endogenous coagulation.
The Hemostatic Agents market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Hemostatic Agents market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Hemostatic Agents Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Hemostatic Agents market are:
B.Braun Melsungen AG
Hemostasis, LLC
Pfizer Inc
Cryolife, Inc.
Atrium Medical Corporation
Advanced Medical Solutions Group
Johnson and Johnson Services Inc
Equimedical
Covidien PLC.
Vascular Solutions, Inc
Z-Medica LLC
Marine Polymer Technologies
Sanofi Group
Gelita GmbH
Mallinckrodt Plc
C.R. Bard Incorporation
Integra Life Sciences Corporation
Baxter International Incorporation

Most important types of Hemostatic Agents products covered in this report are:
Thrombin
Oxidized Regenerated Cellulose
Combination
Gelatin
Collagen
Other

Most widely used downstream fields of Hemostatic Agents market covered in this report are:
Hospitals
Surgical Centers
Nursing Homes

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Hemostatic Agents Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Hemostatic Agents
1.3 Hemostatic Agents Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Hemostatic Agents Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Hemostatic Agents
1.4.2 Applications of Hemostatic Agents
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Hemostatic Agents Industry Trends
1.5.2 Hemostatic Agents Drivers
1.5.3 Hemostatic Agents Market Challenges
1.5.4 Hemostatic Agents Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Hemostatic Agents Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Hemostatic Agents Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Hemostatic Agents Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Hemostatic Agents
2.2.1 Major Players Manufacturing Base of Hemostatic Agents in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Hemostatic Agents Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Hemostatic Agents
2.3.3 Labor Cost of Hemostatic Agents
2.4 Market Channel Analysis of Hemostatic Agents
2.5 Major Down Stream Customers by Application

3 Global Hemostatic Agents Market, by Type
3.1 Global Hemostatic Agents Revenue and Market Share by Type (2018-2021)
3.2 Global Hemostatic Agents Production and Market Share by Type (2018-2021)
3.3 Global Hemostatic Agents Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Hemostatic Agents Revenue and Growth Rate of Thrombin
3.3.2 Global Hemostatic Agents Revenue and Growth Rate of Oxidized Regenerated Cellulose
3.3.3 Global Hemostatic Agents Revenue and Growth Rate of Combination
3.3.4 Global Hemostatic Agents Revenue and Growth Rate of Gelatin
3.3.5 Global Hemostatic Agents Revenue and Growth Rate of Collagen
3.3.6 Global Hemostatic Agents Revenue and Growth Rate of Other
3.4 Global Hemostatic Agents Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Hemostatic Agents Market, by Application
4.1 Downstream Market Overview
4.2 Global Hemostatic Agents Consumption and Market Share by Application (2018-2021)
4.3 Global Hemostatic Agents Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Hemostatic Agents Consumption and Growth Rate of Hospitals (2018-2021)
4.3.2 Global Hemostatic Agents Consumption and Growth Rate of Surgical Centers (2018-2021)
4.3.3 Global Hemostatic Agents Consumption and Growth Rate of Nursing Homes (2018-2021)

5 Global Hemostatic Agents Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Hemostatic Agents Revenue and Market Share by Region (2018-2021)
5.2 Global Hemostatic Agents Consumption and Market Share by Region (2018-2021)
5.3 Global Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Hemostatic Agents Market Under COVID-19
5.4.2 North America Hemostatic Agents SWOT Analysis
5.5 Europe Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Hemostatic Agents Market Under COVID-19
5.5.2 Europe Hemostatic Agents SWOT Analysis
5.6 China Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Hemostatic Agents Market Under COVID-19
5.6.2 China Hemostatic Agents SWOT Analysis
5.7 Japan Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Hemostatic Agents Market Under COVID-19
5.7.2 Japan Hemostatic Agents SWOT Analysis
5.8 Middle East and Africa Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Hemostatic Agents Market Under COVID-19
5.8.2 Middle East and Africa Hemostatic Agents SWOT Analysis
5.9 India Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Hemostatic Agents Market Under COVID-19
5.9.2 India Hemostatic Agents SWOT Analysis
5.10 South America Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Hemostatic Agents Market Under COVID-19
5.10.2 South America Hemostatic Agents SWOT Analysis
5.11 South Korea Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Hemostatic Agents Market Under COVID-19
5.11.2 South Korea Hemostatic Agents SWOT Analysis
5.12 Southeast Asia Hemostatic Agents Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Hemostatic Agents Market Under COVID-19
5.12.2 Southeast Asia Hemostatic Agents SWOT Analysis

6 Global Hemostatic Agents Production by Top Regions (2018-2021)
6.1 Global Hemostatic Agents Production by Top Regions (2018-2021)
6.2 North America Hemostatic Agents Production and Growth Rate
6.3 Europe Hemostatic Agents Production and Growth Rate
6.4 China Hemostatic Agents Production and Growth Rate
6.5 Japan Hemostatic Agents Production and Growth Rate
6.6 India Hemostatic Agents Production and Growth Rate

7 Global Hemostatic Agents Consumption by Regions (2018-2021)
7.1 Global Hemostatic Agents Consumption by Regions (2018-2021)
7.2 North America Hemostatic Agents Consumption and Growth Rate
7.3 Europe Hemostatic Agents Consumption and Growth Rate
7.4 China Hemostatic Agents Consumption and Growth Rate
7.5 Japan Hemostatic Agents Consumption and Growth Rate
7.6 Middle East & Africa Hemostatic Agents Consumption and Growth Rate
7.7 India Hemostatic Agents Consumption and Growth Rate
7.8 South America Hemostatic Agents Consumption and Growth Rate
7.9 South Korea Hemostatic Agents Consumption and Growth Rate
7.10 Southeast Asia Hemostatic Agents Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 B.Braun Melsungen AG Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Hemostatic Agents Product Profiles, Application and Specification
8.2.3 B.Braun Melsungen AG Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Hemostasis, LLC Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Hemostatic Agents Product Profiles, Application and Specification
8.3.3 Hemostasis, LLC Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Pfizer Inc Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Hemostatic Agents Product Profiles, Application and Specification
8.4.3 Pfizer Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Cryolife, Inc. Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Hemostatic Agents Product Profiles, Application and Specification
8.5.3 Cryolife, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Atrium Medical Corporation Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Hemostatic Agents Product Profiles, Application and Specification
8.6.3 Atrium Medical Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Advanced Medical Solutions Group Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Hemostatic Agents Product Profiles, Application and Specification
8.7.3 Advanced Medical Solutions Group Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Johnson and Johnson Services Inc Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Hemostatic Agents Product Profiles, Application and Specification
8.8.3 Johnson and Johnson Services Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Equimedical Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Hemostatic Agents Product Profiles, Application and Specification
8.9.3 Equimedical Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Covidien PLC. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Hemostatic Agents Product Profiles, Application and Specification
8.10.3 Covidien PLC. Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Vascular Solutions, Inc Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Hemostatic Agents Product Profiles, Application and Specification
8.11.3 Vascular Solutions, Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Z-Medica LLC Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Hemostatic Agents Product Profiles, Application and Specification
8.12.3 Z-Medica LLC Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Marine Polymer Technologies Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Hemostatic Agents Product Profiles, Application and Specification
8.13.3 Marine Polymer Technologies Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Sanofi Group Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Hemostatic Agents Product Profiles, Application and Specification
8.14.3 Sanofi Group Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Gelita GmbH Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Hemostatic Agents Product Profiles, Application and Specification
8.15.3 Gelita GmbH Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Mallinckrodt Plc Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Hemostatic Agents Product Profiles, Application and Specification
8.16.3 Mallinckrodt Plc Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 C.R. Bard Incorporation Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Hemostatic Agents Product Profiles, Application and Specification
8.17.3 C.R. Bard Incorporation Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Integra Life Sciences Corporation Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Hemostatic Agents Product Profiles, Application and Specification
8.18.3 Integra Life Sciences Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Baxter International Incorporation Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Hemostatic Agents Product Profiles, Application and Specification
8.19.3 Baxter International Incorporation Sales, Revenue, Price, Gross Margin 2018-2021
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Hemostatic Agents Market Analysis and Forecast by Type and Application
9.1 Global Hemostatic Agents Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Thrombin Market Revenue and Volume Forecast (2021-2026)
9.1.2 Oxidized Regenerated Cellulose Market Revenue and Volume Forecast (2021-2026)
9.1.3 Combination Market Revenue and Volume Forecast (2021-2026)
9.1.4 Gelatin Market Revenue and Volume Forecast (2021-2026)
9.1.5 Collagen Market Revenue and Volume Forecast (2021-2026)
9.1.6 Other Market Revenue and Volume Forecast (2021-2026)
9.2 Global Hemostatic Agents Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospitals Market Revenue and Volume Forecast (2021-2026)
9.2.2 Surgical Centers Market Revenue and Volume Forecast (2021-2026)
9.2.3 Nursing Homes Market Revenue and Volume Forecast (2021-2026)

10 Hemostatic Agents Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Hemostatic Agents Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Healthcare IT Industry